| Cystic Fibrosis (CF) is an autosomal recessive genetic
disorder characterized by chronic pulmonary disease, pancreatic insufficiency,
and male infertility. The disease frequency is approximately one in 2,500
newborns, and the estimated carrier frequency in the Caucasian and Ashkenazi
Jewish populations is approximately 1 in 25. This disorder is caused
by mutations in two copies of the Cystic Fibrosis Transmembrane Regulator
gene (CFTR). Most CFTR mutations can be identified through targeted CF
mutation detection panels. For individuals who are negative for mutations
by targeted mutation testing, DNA sequence analysis of the entire CFTR gene
coding region is available at the Baylor Medical Genetics Laboratories.
- Confirmation of a clinical diagnosis of CF
- Testing of at-risk family members (known familial mutations)
- Determination of reproductive risk in partners of known CF carriers who are negative for CF mutations in clinically available mutation panels
- Prenatal Diagnosis (known familial mutations)
PCR amplification of 27 exons contained in the CFTR gene
coding region will be performed on patient genomic DNA. Direct sequencing
of amplification products is performed in both the forward and reverse
directions using automated fluorescence dideoxy sequencing methods.
Analytical: ~99%
Clinical: ~98%
Blood for DNA:
EDTA (purple-top) tubes: Adults: 14
cc; Child/Infant: 6 cc
Requisition form must accompany specimen. Prior to any genetic testing, we recommend
genetic counseling and request that the subject, or their legal guardian, sign
our consent form and submit it with the sample. To receive our forms
and information about prenatal testing, please contact our laboratory.
4
weeks
Index: 83891, 83898X29, 83894, 83904x58, 83909x58,
83912
Known Familial Mutation: 83891, 83898, 83894, 83904x2, 83909x2, 83912
>> Gene
Sequencing Requisition
>> DNA
Requisition
>> Prenatal
Requisition
1. Strom CM, Huang D, Chen C, Buller A, Peng
M, Quan F, Redman J, Sun W (2003) Extensive sequencing of the cystic fibrosis
transmembrane regulator gene: assay validation and unexpected benefits
of developing a comprehensive test. Genet Med 2003.5: 9-14.
2. Matthew J. McGinniss, Christina Chen Joy B. Redman,
Arlene Buller, Franklin Quan Mei Peng , Robert Giusti, Feras M. Hantash,
Donghui Huang, Weimin Sun, Charles M. Strom Extensive Sequencing of the
CFTR gene: lessons learned from the first 157 patient samples Hum Genet
2005 118:331-338.
Index: 6370
Known Familial Mutation: 6371
Prenatal: 6372
Last Modified: 3-24-08
|